Deep Braining...
TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

BioCardia, Inc. Common Stock (BCDA)
BioCardia, Inc. Common Stock
XNAS:BCDA
1.39
-3.47%

Ask
$2.50 - 1,000.00
Bid
$1.13 - 100.00
Low
$1.37
High
$1.46
Open
$1.46
Prev Close
$1.44
52W High
3.2
52W Low
1
Volume
44541
Avg Vol (3m)
66052.2
Float
4973259.8
Chart
TendieTensor AI Analysis

Company
Asset Type: Common Stock
SIC Code: 2836
Sector: Health Technology
Industry: Biotechnology
Date Listed: 10/25/1995
Primary Exchange: XNAS

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

Phone: 650-226-0123
Address: 320 Soquel Way
City: Sunnyvale
State: CA
Postal Code: 94085
TendieTensor AI Analyst Recommendation:
Fundamentals
Total Employees:
17
P/E (TTM)
-0.810000
P/B (TTM)
5.855510
EPS
-0.24
Round Lot
100
Composit FIGI
BBG000BTJTF3
Share Class FIGI
BBG001S72MS0
Share Class Shares Outstanding
5.81M
Weighted Shares Outstanding
10.61M

Technicals
RSI (14)
MACD Line
MACD Signal
SMA 20
SMA 50
EMA 50
Trend
Short Interest
Days to Cover
Higher = harder to cover
Short Interest Δ
Prev: —
Short Volume Ratio (Today)
5D avg:
Squeeze Score (0–100)
Discussion
Login to participate in discussions.
Recent News
Related Stocks

Based on the portfolios of people who own BCDA. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.